The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Delivery of Epitopes by the Salmonella Type III Secretion System for Vaccine Development
Abstract
Avirulent strains of Salmonella typhimurium are being considered as antigen delivery vectors. During its intracellular stage in the host, S. typhimurium resides within a membrane-bound compartment and is not an efficient inducer of class I–restricted immune responses. Viral epitopes were successfully delivered to the host-cell cytosol by using the type III protein secretion system of S. typhimurium . This resulted in class I–restricted immune responses that protected vaccinated animals against lethal infection. This approach may allow the efficient use of S. typhimurium as an antigen delivery system to control infections by pathogens that require this type of immune response for protection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines
Hoiseth, S. K., & Stocker, B. A. D. (1981) · Nature · doi:10.1038/291238a0 · Cited by 2,078
Wang, R. F., & Kushner, S. R. (1991) · Gene · doi:10.1016/0378-1119(91)90366-j · Cited by 1,170
Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells
Rötzschke, O., Falk, K., Deres, K., Schild, H., Norda, M., Metzger, J., Jung, G., & Rammensee, H.-G. (1990) · Nature · doi:10.1038/348252a0 · Cited by 769
Ljunggren, H. G., & Kärre, K. (1985) · The Journal of experimental medicine · doi:10.1084/jem.162.6.1745 · Cited by 736
Molecular genetic bases of Salmonella entry into host cells
Galán, J. E. (1996) · Molecular Microbiology · doi:10.1111/j.1365-2958.1996.tb02615.x · Cited by 435
Oral Somatic Transgene Vaccination Using Attenuated S. typhimurium
Darji, A., Guzmán, C. A., Gerstel, B., Wachholz, P., Timmis, K. N., Wehland, J., Chakraborty, T., & Weiss, S. (1997) · Cell · doi:10.1016/s0092-8674(00)80465-1 · Cited by 396
Applications of pox virus vectors to vaccination: an update.
Paoletti, E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11349 · Cited by 344
Collazo, C. M., & Galán, J. E. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.3781740.x · Cited by 300
Ham-2 corrects the class I antigen-processing defect in RMA-S cells
Attaya, M., Jameson, S., Martinez, C. K., Hermel, E., Aldrich, C., Forman, J., Lindahl, K. F., Bevan, M. J., & Monaco, J. J. (1992) · Nature · doi:10.1038/355647a0 · Cited by 285
Galán, J. E., Nakayama, K., & Curtiss, R. (1990) · Gene · doi:10.1016/0378-1119(90)90464-3 · Cited by 283
Kaniga, K., Uralil, J., Bliska, J. B., & Galán, J. E. (1996) · Molecular Microbiology · doi:10.1111/j.1365-2958.1996.tb02571.x · Cited by 239
Kaniga, K., Trollinger, D., & Galán, J. E. (1995) · Journal of Bacteriology · doi:10.1128/jb.177.24.7078-7085.1995 · Cited by 223
CROSS-TALK BETWEEN BACTERIAL PATHOGENS AND THEIR HOST CELLS
Galán, J. E., & Bliska, J. B. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.221 · Cited by 152
Deckhut, A. M., Allan, W., McMickle, A., Eichelberger, M. C., Blackman, M. A., Doherty, P. C., & Woodland, D. L. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.5.2658 · Cited by 145
Whitton, J. L., Tishon, A., Lewicki, H. A., Gebhard, J., Cook, T., Salvato, M. S., Joly, E., & Oldstone, M. B. A. (1989) · Journal of Virology · doi:10.1128/jvi.63.10.4303-4310.1989 · Cited by 136
Ossevoort, M. A., Feltkamp, M. C. W., van Veen, K. J. H., Melief, C. J. M., & Kast, W. M. (1995) · Journal of Immunotherapy · doi:10.1097/00002371-199508000-00002 · Cited by 129
Recombinant viruses as vaccines and immunological tools
Rolph, M. S., & Ramshaw, I. A. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80104-5 · Cited by 45
Efficiency and effectiveness of cloned virus-specific cytotoxic T lymphocytes in vivo.
Klavinskis, L. S., Tishon, A., & Oldstone, M. B. A. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.6.2013 · Cited by 40
Strategies for the development of recombinant vaccines for the immunotherapy of breast cancer
Schlom, J., Kantor, J. A., Abrams, S. I., Tsang, K. Y., Panicali, D., & Hamilton, J. M. (1996) · Breast Cancer Research and Treatment · doi:10.1007/bf01803781 · Cited by 39
Future vaccines and a global perspective
Katz, S. L. (1997) · The Lancet · doi:10.1016/s0140-6736(97)05358-0 · Cited by 34
Gao, X. M., Tite, J. P., Lipscombe, M., Rowland-Jones, S. L., Ferguson, D. J. P., & McMichael, A. J. (1992) · Infection and Immunity · doi:10.1128/iai.60.9.3780-3789.1992 · Cited by 32
Use of Salmonella for heterologous gene expression and vaccine delivery systems
Hackett, J. (1993) · Current Opinion in Biotechnology · doi:10.1016/0958-1669(93)90085-b · Cited by 20
Ringrose, J. H., Yard, B. A., Verjans, G. M. G. M., & Boog, C. J. P. (1996) · Clinical Rheumatology · doi:10.1007/bf03342653 · Cited by 4
Cited by
Protein delivery into eukaryotic cells by type III secretion machines
Galán, J. E., & Wolf-Watz, H. (2006) · Nature · doi:10.1038/nature05272 · Cited by 1,041
Tumour-targeting bacteria engineered to fight cancer
Zhou, S., Gravekamp, C., Bermudes, D., & Liu, K. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0070-z · Cited by 821
Pathogenicity Islands in BacterialPathogenesis
Schmidt, H., & Hensel, M. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.1.14-56.2004 · Cited by 776
Bacteria-cancer interactions: bacteria-based cancer therapy
Duong, M. T.-Q., Qin, Y., You, S.-H., & Min, J.-J. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0297-0 · Cited by 519
CD8 T Cell Responses to Infectious Pathogens
Wong, P., & Pamer, E. G. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141114 · Cited by 425
Metadata
- Authors
- Rüssmann, H., Shams, H., Poblete, F., Fu, Y., Galán, J. E., & Donis, R. O.
- Venue
- Science
- Published
- 1998-07-24
- Volume
- 281
- Issue
- 5376
- Pages
- 565-568
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2163002490
- Cited by
- 276
- References
- 23
- FWCI
- 6.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.